Cargando…
Resurgence of Polymyxin B for MDR/XDR Gram-Negative Infections: An Overview of Current Evidence
Polymyxin B has resurged in recent years as a last resort therapy for Gram-negative multidrug-resistant (MDR) and extremely drug resistant (XDR) infections. Understanding newer evidence on polymyxin B is necessary to guide clinical decision making. Here, we present a literature review of polymyxin B...
Autores principales: | Garg, Suneel Kumar, Singh, Omender, Juneja, Deven, Tyagi, Niraj, Khurana, Amandeep Singh, Qamra, Amit, Motlekar, Salman, Barkate, Hanmant |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518490/ https://www.ncbi.nlm.nih.gov/pubmed/28761764 http://dx.doi.org/10.1155/2017/3635609 |
Ejemplares similares
-
Effectiveness and Nephrotoxicity of Intravenous Polymyxin B in Chinese Patients With MDR and XDR Nosocomial Pneumonia
por: Zeng, Huihui, et al.
Publicado: (2021) -
MDR & XDR Tuberculosis
por: Kumar, Prahlad
Publicado: (2017) -
The Role of Adjunctive Therapies in Septic Shock by Gram Negative MDR/XDR Infections
por: Busani, Stefano, et al.
Publicado: (2017) -
Clinical Profile, Intensive Care Unit Course, and Outcome of Patients Admitted in Intensive Care Unit with Chikungunya
por: Gupta, Anish, et al.
Publicado: (2018) -
Hepatitis A Virus-induced Severe Hemolysis Complicated by Severe Glucose-6-Phosphate Dehydrogenase Deficiency
por: Sharma, Dhruva, et al.
Publicado: (2018)